|

obrixtamig Clinical Trials

3 actively recruiting trials across 3 locations

▲ +1 trial since September 2026

Also known as: BI 764532

Pipeline

Phase 3: 2Phase 1/2: 1

Top Sponsors

  • Boehringer Ingelheim3

Indications

  • Cancer3
  • Lung Cancer2
  • Advanced Small Cell Lung Cancer1
  • Extensive-stage Small Cell Lung Carcinoma1
  • Extrapulmonary Neuroendocrine Cancer (epNEC)1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.